satsumarx.com
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Areas of Focus
    • Migraine
    • Dihydroergotamine
  • Our Research
    • STS101
    • Publications
    • Clinical Trials
  • Information
    • Press Releases
    • SEC Filings
      • Insider Transactions
    • Resources
      • Email Alerts
      • Information Request
  • Contact

SEC Filings

  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Areas of Focus
    • Migraine
    • Dihydroergotamine
  • Our Research
    • STS101
    • Publications
    • Clinical Trials
  • Information
    • Press Releases
    • SEC Filings
      • Insider Transactions
    • Resources
      • Email Alerts
      • Information Request
  • Contact
Satsuma Pharmaceuticals
YearCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2016
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
satsumarx.com
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Areas of Focus
    • Migraine
    • Dihydroergotamine
  • Our Research
    • STS101
    • Publications
    • Clinical Trials
  • Information
    • Press Releases
    • SEC Filings
      • Insider Transactions
    • Resources
      • Email Alerts
      • Information Request
  • Contact

 ©2024 Satsuma Pharmaceuticals, Inc. All Rights Reserved. | Terms of Use | Privacy Policy

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Areas of Focus
    • Migraine
    • Dihydroergotamine
  • Our Research
    • STS101
    • Publications
    • Clinical Trials
  • Information
    • Press Releases
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Investor Relations
  • Contact